Showing results (101-110 of 370) with videos related to

Sort By:
Pageof 37
Plos One|March 26, 2013
Drug users in Amsterdam: are they still at risk for HIV?Nienke van der Knaap, Bart P X Grady, Maarten F Schim van der Loeff, et al.
AIDS (London, England)|September 9, 2004
Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infectionLiselotte van Asten, Figen Danisman, Sigrid A Otto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2010
Absence of HIV-1 superinfection 1 year after infection between 1985 and 1997 coincides with a reduction in sexual risk behavior in the seroincident Amsterdam cohort of homosexual menAndrea Rachinger, Ineke G Stolte, Tom Derks van de Ven, et al.
The Lancet. Infectious Diseases|May 1, 2012
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineJason Grebely, Maria Prins, Margaret Hellard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2014
Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort studyJudith Schouten, Ferdinand W Wit, Ineke G Stolte, et al.
AIDS (London, England)|August 23, 2011
Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSMFemke A E Lambers, Maria Prins, Xiomara Thomas, et al.
AIDS (London, England)|October 1, 2024
Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized preexposure prophylaxis care in Amsterdam, the NetherlandsEline Wijstma, Vita W Jongen, Anders Boyd, et al.
European Journal of Preventive Cardiology|June 6, 2017
Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapyRosan A van Zoest, Marc van der Valk, Ferdinand W Wit, et al.
BMC Public Health|January 24, 2014
Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic reviewFreke R Zuure, Anouk T Urbanus, Miranda W Langendam, et al.
Sociology of Health & Illness|May 17, 2021
The social meanings of PrEP use - A mixed-method study of PrEP use disclosure in Antwerp and AmsterdamThijs Reyniers, Hanne M L Zimmermann, Udi Davidovich, et al.
Pageof 37